NCT05533073 - Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

September 7, 2020

Study Completion Date

November 30, 2020

Conditions

Healthy

Interventions

DRUG

A1: Etoricoxib / Tramadol Fixed dose combination

Sachet with granules (Laboratorios Silanes S.A. de C.V.). Formula : 90 mg/ 50 mg Pharmaceutical Form: Sachet with granules Dosage: 100 mL (90 mg/ 50mg) Administration way: oral

DRUG

A2: Etoricoxib

Arcoxia®, Schering Plough S.A. de C.V. A2: Pharmaceutical Form: Tablet Formula: 90 mg Dosage: 1 tablet of 90 mg Administration way: oral

DRUG

A3: Tramadol

Tradol®, from Grünenthal GMBH. Pharmaceutical Form: Capsule Formula: Each capsule contains 50 mg Dosage: 1 capsule of 50 mg Administration way: oral

Trial Locations (1)

11000

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors

lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY